<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03212885</url>
  </required_header>
  <id_info>
    <org_study_id>16-1443</org_study_id>
    <nct_id>NCT03212885</nct_id>
  </id_info>
  <brief_title>Stimulation of the Rostral Zona Incerta for Parkinson's Disease</brief_title>
  <official_title>Deep Brain Stimulation (DBS) of the Rostral Zona Incerta (rZI) for Parkinson's Disease (PD): Clinical Efficacy and Evaluation of Adverse Effects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with Parkinson's Disease who undergo Deep Brain Stimulation surgery receive symptom
      relief due to electrical stimulation of the brain. The target for the stimulation, in many
      cases, is the subthalamic nucleus (STN). The brain area just above the STN is called the
      rostral Zona Incerta (rZI). The rZI may be a potential target for deep brain stimulation, in
      combination with the STN.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Deep brain stimulation (DBS) of an area of the brain called the subthalamic nucleus (STN) is
      an effective treatment in Parkinson's disease (PD). However, stimulating the STN can lead to
      unwanted side effects that involve muscle movements (dyskinesias) and behavior and mood
      problems. DBS of a different brain structure, called the rostral zona incerta (rZI), has been
      demonstrated to be as effective as stimulating the STN, without any unwanted side effects in
      several studies. However, there is great variability in reported efficacy and adverse effects
      of rZI stimulation likely due to challenges in locating this area in the brain. The goals of
      this study are 1) to develop an improved method for targeting the rZI 2) determine efficacy
      of rZI with STN stimulation compared with STN stimulation alone, 3) evaluate any stimulation
      adverse effects of combined stimulation of the rZI and STN.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 3, 2017</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Motor testing</measure>
    <time_frame>1 week</time_frame>
    <description>Blinded UPDRS testing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dyskinesias</measure>
    <time_frame>1 week</time_frame>
    <description>Unified Dyskinesia Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognition</measure>
    <time_frame>1 week</time_frame>
    <description>Montreal Cognitive Assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>1 week</time_frame>
    <description>Hamilton Depression Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>1 week</time_frame>
    <description>Hamilton Anxiety Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicide</measure>
    <time_frame>1 week</time_frame>
    <description>Columbia Suicide Severity Ratting Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-motor features of Parkinson's disease</measure>
    <time_frame>1 week</time_frame>
    <description>Movement Disorder Society-UPDRS I</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor aspects of daily living</measure>
    <time_frame>1 week</time_frame>
    <description>Movement Disorder Society-UPDRS II</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">81</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>STN Monopolar Stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rZI + STN stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation</intervention_name>
    <description>Electrode that provides electrical stimulation to deep brain structures for relief of Parkinson's Disease symptoms.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parkinson's Disease,

          -  No current deep brain stimulating electrodes

        Exclusion Criteria:

          -  Other movement disorders,

          -  Parkinson's Disease with already implanted electrode.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Drew S Kern, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pamela David Gerecht, PhD</last_name>
    <phone>303-724-4134</phone>
    <email>pamela.davidgerecht@ucdenver.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Drew Kern, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2017</study_first_submitted>
  <study_first_submitted_qc>July 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2017</study_first_posted>
  <last_update_submitted>July 17, 2017</last_update_submitted>
  <last_update_submitted_qc>July 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Deep Brain Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

